Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kyowa Hakko Bio has pioneered industrial-scale fermentation processes since the mid-twentieth century. The company supplies high-purity amino acids, nucleic acid-related compounds like citicoline (Cognizin®), peptides such as L-Alanyl-L-glutamine, and other specialty ingredients globally. Its products are used in pharmaceuticals, dietary supplements, food additives, cosmetics, and industrial applications. The company does not develop finished drugs but provides key active ingredients with proven safety/efficacy profiles for use by pharmaceutical companies or supplement brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kyowa Hakko Bio.